Drug companies are quietly pushing through price hikes of 100% — or even more than 1,000% — for a very small but growing number of prescription drugs, helping to drive up costs for insurers, patients and government programs.
Among the examples: Questcor Pharmaceuticals last August raised the wholesale price on Acthar, which treats spasms in babies, from about $1,650 a vial to more than $23,000. Ovation raised the cost of Cosmegen, which treats a type of tumor, from $16.79 to $593.75 in January 2006.
The average wholesale price of 26 brand-name drugs jumped 100% or more in a single cost adjustment last year, up from 15 in 2004, the university study found. In the first half of this year, 17 drugs made the list.
Within months of being soaked with a glyphosate herbicide while working on a cell tower maintenance...
Diary entries released by a Republican senator in an attempt to damage Anthony Fauci also show...
In March in a McDonald's parking lot off a busy Baltimore street, mental health clinician Michala...
The Ebola outbreak in the Democratic Republic of Congo has continued to spread, with the number...
